Year: 2025
Type: article
Abstract: Azithromycin is a macrolide antibiotic active against many aerobic Gram-positive and Gram-negative bacteria, including intracellular pathogens such as Chlamydia trachomatis. Oral solid, oral liquid and intravenous azithromycin formulations have been authorised for decades in the European Union (EU) in a wide range of infections commonly seen in the community, such as infections of the respiratory tract, the skin, the urogenital tract, and others.
Authors: Robin Ruepp, Radu Botgros, Veronique Le Ber, Franziska Brandt, Ellen Pantke, Miriam Fuerst-Wilmes, Antonio Gomez-Outes, Maria Jesus Fernandez-Cortizo
Language: English
Subfield: Applied Microbiology and Biotechnology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W7117258319